Skip Navigation LinksHome > November 2002 - Volume 100 - Issue 5, Part 2 > Successful Treatment of Extremely Severe Fetal Anemia Due to...
Obstetrics & Gynecology:
Case Reports

Successful Treatment of Extremely Severe Fetal Anemia Due to Kell Alloimmunization

Collinet, P. MD; Subtil, D. MD; Puech, F. PhD; Vaast, P. MD

Collapse Box


BACKGROUND: Repeated plasmapheresis was used to prevent fetal death from severe anti-Kell alloimmunization until intrauterine transfusions were feasible.

CASE: Repeated maternal plasma exchanges (N = 40) beginning at 7 weeks' gestation were used to treat severe anti-Kell alloimmunization. Ultrasound examination at 19 weeks' gestation revealed diffuse hydrops in this fetus (umbilical venous hemoglobin, 1.2 g/dL), which then required nine intrauterine transfusions through 34 weeks. A healthy 3840-g girl was delivered by cesarean delivery at 36 weeks. Despite aplastic anemia during the first 3 months of life, she is healthy and has no observable abnormalities at age 8.

CONCLUSION: A highly aggressive course of plasmapheresis and intrauterine transfusions can successfully treat fetal anemia caused by anti-Kell alloimmunization even when fetal hemoglobin is extremely low.

© 2002 The American College of Obstetricians and Gynecologists


Article Tools